What's Happening?
Cytiva and Rockwell Automation have introduced the Figurate SCADA system, designed to eliminate digital bottlenecks in biopharmaceutical manufacturing. This system provides seamless connectivity across multiple instrument vendors and modalities, facilitating
digital integration in modern bioprocessing. The Figurate SCADA system features native interoperability with Cytiva bioprocessing equipment and Rockwell Automation’s FactoryTalk software, scalable growth from process development to commercial manufacturing, and cost-effective compliance with cGMP standards. It also offers rapid implementation through pre-engineered templates and modular design, enhancing operational insight with centralized alarms and real-time monitoring.
Why It's Important?
The launch of the Figurate SCADA system is a pivotal development for the biopharmaceutical industry, which faces increasing pressure to accelerate production timelines while maintaining high standards of data integrity and compliance. By providing a unified digital control layer, the system reduces the risk of human error, accelerates technology transfer, and supports reliable scale-up as manufacturing processes grow in complexity. This advancement is particularly significant as the industry moves towards data-driven process intensification and continuous manufacturing, addressing one of the major challenges of equipment fragmentation and operational silos.
What's Next?
As the biopharmaceutical industry continues to evolve, the adoption of advanced process control systems like Figurate SCADA will likely become more widespread. Companies will need to focus on integrating these systems into their existing operations to fully leverage their capabilities. The industry can expect further innovations in digital manufacturing technologies, which will enhance efficiency and reduce costs. Additionally, as more organizations transition to these advanced systems, there will be a growing need for skilled professionals who can manage and optimize these technologies.
